A portion of the caption for Fig 5 is incorrectly duplicated within the Fig 6 caption. Additionally, the *, #, and † symbols are incorrectly assigned within the captions of Figs 5, 6, 7 and 8. Please see the corrected captions here.
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 5. Implantation of HGF-modified skeletal myoblasts increases the HGF and VEGF expression in the myocardium.
The Ad-GFP- or Ad-HGF- transduced myoblasts were implanted into the myocardium in an MI model for 7 days. The protein levels of HGF (a) and VEGF (b) in the transplanted area were determined by ELISA. (c) Western blot was performed for Bcl-2 expression in SM transduced with Ad-HGF, vector control, and cell control group. (d) The ratio of Bcl-2 to β-actin in the transplanted area was evaluated by Western blot (Fig 5a and Fig 5b: n = 6, P<0.05, *P<0.05 vs. control group; #P<0.05 vs. SM group; †P<0.05 vs. SM-GFP group. Fig 5d: n = 6, P<0.05, *P<0.05 vs. SM group; #P<0.05 vs. SM-GFP group).
https://doi.org/10.1371/journal.pone.0196413.g001
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 6. Implantation of HGF-modified skeletal myoblasts improves the heart function.
The Ad-GFP or Ad-HGF transduced myoblasts were implanted into the myocardium in an MI model for 28 days. The cardiac functional parameters including LVSP (a) and +dp/dtmax (b), LVEDP (c), and dp/dtmin (d) were detected (n = 6, P<0.05, *P<0.05 vs. control group; #P<0.05 vs. SM group; †P<0.05 vs. SM-GFP group).
https://doi.org/10.1371/journal.pone.0196413.g002
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 7. Implantation of HGF-modified skeletal myoblasts reduces infarct area and reduces collagen deposition.
The Ad-GFP- or Ad-HGF-transduced myoblasts were implanted into the myocardium in an MI model for 28 days. (a) Representative images of histological sections in left ventricular stained with HE. Scale bars, 1 mm. (b) Images show that Sirius Red stained the cardiac sections from SM-GFP, SM only, SM-HGF group, and sham group, respectively. (c) The collagen volume fraction of SM-HGF group compared to the control group and SM group (n = 6, P<0.05, *P<0.05 vs. control group; #P<0.05 vs. SM group; †P<0.05 vs. SM-GFP group).
https://doi.org/10.1371/journal.pone.0196413.g003
thumbnail
Download:
*
PPT
PowerPoint slide
*
PNG
larger image
*
TIFF
original image
Fig 8. Implantation of HGF-modified skeletal myoblasts increase the vessel density.
The Ad-GFP- or Ad-HGF-transduced myoblasts were implanted into the myocardium in an MI model for 28 days. (a) Sections were stained with antibodies against Factor VIII to facilitate the counting of vessels. The representative images of the capillary density in transplanted area were shown. (b) The numbers of vascular densities of groups indicated (n = 6, P<0.05, *P<0.05 vs. control group; #P<0.05 vs. SM group; †P<0.05 vs. SM-GFP group).
https://doi.org/10.1371/journal.pone.0196413.g004
1. Rong S-L, Wang X-L, Zhang C-Y, Song Z-H, Cui L-H, He X-F, et al. (2017) Transplantation of HGF gene-engineered skeletal myoblasts improve infarction recovery in a rat myocardial ischemia model. PLoS ONE 12(5): e0175807. https://doi.org/10.1371/journal.pone.0175807 pmid:28459804
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2018 Rong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
The protein levels of HGF (a) and VEGF (b) in the transplanted area were determined by ELISA. (c) Western blot was performed for Bcl-2 expression in SM transduced with Ad-HGF, vector control, and cell control group. (d) The ratio of Bcl-2 to β-actin in the transplanted area was evaluated by Western blot (Fig 5a and Fig 5b: n = 6, P<0.05, *P<0.05 vs. control group; #P<0.05 vs. Scale bars, 1 mm. (b) Images show that Sirius Red stained the cardiac sections from SM-GFP, SM only, SM-HGF group, and sham group, respectively. (c) The collagen volume fraction of SM-HGF group compared to the control group and SM group (n = 6, P<0.05, *P<0.05 vs. control group; #P<0.05 vs. The representative images of the capillary density in transplanted area were shown. (b) The numbers of vascular densities of groups indicated (n = 6, P<0.05, *P<0.05 vs. control group; #P<0.05 vs.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer